Immunocytokines: a review of molecules in clinical development for cancer therapy

Thomas List, Dario NeriDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, SwitzerlandAbstract: The concept of therapeutically enhancing the immune system’s responsiveness to tumors is long standing. Several cytokines have b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: List T, Neri D
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/7a4cbd9c552f43488fba4cfb8dd52d4f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7a4cbd9c552f43488fba4cfb8dd52d4f
record_format dspace
spelling oai:doaj.org-article:7a4cbd9c552f43488fba4cfb8dd52d4f2021-12-02T02:48:28ZImmunocytokines: a review of molecules in clinical development for cancer therapy1179-1438https://doaj.org/article/7a4cbd9c552f43488fba4cfb8dd52d4f2013-08-01T00:00:00Zhttp://www.dovepress.com/immunocytokines-a-review-of-molecules-in-clinical-development-for-canc-a14092https://doaj.org/toc/1179-1438Thomas List, Dario NeriDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, SwitzerlandAbstract: The concept of therapeutically enhancing the immune system’s responsiveness to tumors is long standing. Several cytokines have been investigated in clinical trials for their therapeutic activity in cancer patients. However, substantial side effects and unfavorable pharmacokinetic properties have been a major drawback hampering the administration of therapeutically relevant doses. The use of recombinant antibody–cytokine fusion proteins promises to significantly enhance the therapeutic index of cytokines by targeting them to the site of disease. This review aims to provide a concise and complete overview of the preclinical data and clinical results currently available for all immunocytokines having reached clinical development.Keywords: antibodies, cytokines, preclinicalList TNeri DDove Medical PressarticleTherapeutics. PharmacologyRM1-950ENClinical Pharmacology: Advances and Applications, Vol 2013, Iss Supplement 1, Pp 29-45 (2013)
institution DOAJ
collection DOAJ
language EN
topic Therapeutics. Pharmacology
RM1-950
spellingShingle Therapeutics. Pharmacology
RM1-950
List T
Neri D
Immunocytokines: a review of molecules in clinical development for cancer therapy
description Thomas List, Dario NeriDepartment of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, SwitzerlandAbstract: The concept of therapeutically enhancing the immune system’s responsiveness to tumors is long standing. Several cytokines have been investigated in clinical trials for their therapeutic activity in cancer patients. However, substantial side effects and unfavorable pharmacokinetic properties have been a major drawback hampering the administration of therapeutically relevant doses. The use of recombinant antibody–cytokine fusion proteins promises to significantly enhance the therapeutic index of cytokines by targeting them to the site of disease. This review aims to provide a concise and complete overview of the preclinical data and clinical results currently available for all immunocytokines having reached clinical development.Keywords: antibodies, cytokines, preclinical
format article
author List T
Neri D
author_facet List T
Neri D
author_sort List T
title Immunocytokines: a review of molecules in clinical development for cancer therapy
title_short Immunocytokines: a review of molecules in clinical development for cancer therapy
title_full Immunocytokines: a review of molecules in clinical development for cancer therapy
title_fullStr Immunocytokines: a review of molecules in clinical development for cancer therapy
title_full_unstemmed Immunocytokines: a review of molecules in clinical development for cancer therapy
title_sort immunocytokines: a review of molecules in clinical development for cancer therapy
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/7a4cbd9c552f43488fba4cfb8dd52d4f
work_keys_str_mv AT listt immunocytokinesareviewofmoleculesinclinicaldevelopmentforcancertherapy
AT nerid immunocytokinesareviewofmoleculesinclinicaldevelopmentforcancertherapy
_version_ 1718402170605273088